BRENTWOOD, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) — Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2025 results after market close on Monday, March 2, 2026, to be followed by a conference call on Tuesday, March 3, 2026 at 8:30 a.m. (Eastern Time). You can join the call as follows:Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international) Replay (available 3 hours after the call and available until March 17, 2026): 1-844-512-2921 (domestic), 1-412-317-6671 (international) Passcode for the live call and the replay: 13758530Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging...

MEXICO CITY, Feb. 24, 2026 (GLOBE NEWSWIRE) — Volaris reports that as of yesterday afternoon, all its operations, including those at Guadalajara (GDL) and Puerto Vallarta (PVR) airports, are running normally. We continue supporting customers whose itineraries were unfortunately affected by offering them various solutions and alternatives through the “My Trips” section on volaris.com, or via WhatsApp at +52 55 5898 8599 for those who prefer personalized assistance. Volaris appreciates the understanding and patience of its customers during this external situation and reiterates its commitment to maintaining a safe and reliable operation at all times. Twitter: @viajaVolarisFacebook: viajavolaris Exclusive contact for mediaClaudia Silva | csilva@gcya.net | +52 55 4577 0806

CINCINNATI, Feb. 24, 2026 (GLOBE NEWSWIRE) — The Scripps Howard Fund and Scripps Howard Foundation, nonprofit organizations, awarded $11 million to community and journalism programs during 2025, a 12% increase from 2024. The Scripps Howard Fund and Scripps Howard Foundation support communities where The E.W. Scripps Company does business, while their journalism programs and funding reach people across the country. The Fund and Foundation also partner with the Scripps and Howard families to support causes important to them. “In 2025, we saw communities across the country strengthened through the power of connection – whether it was giving children the gift of books, equipping aspiring journalists with the skills to tell important stories or rallying together in times of crisis,” said Meredith Delaney, president and CEO of the Scripps...

PITTSBURGH, Feb. 24, 2026 (GLOBE NEWSWIRE) — L.B. Foster Company (Nasdaq: FSTR, the “Company”), today announced that it will release its fourth quarter and full year 2025 operating results, pre-market opening on Tuesday, March 3, 2026. L.B. Foster will host a conference call to discuss its operating results, market outlook, and developments in the business that morning at 8:30 A.M. Eastern Time. A presentation will be available on the Company’s website under the Investor Relations page immediately after the Company’s earnings release. The conference call will be webcasted live through L.B. Foster’s Investor Relations page of the Company’s website (www.lbfoster.com). The webcast is listen-only. A webcast replay will be available through March 10, 2026, on L.B. Foster’s Investor Relations page. Those interested in participating in...

CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company’s biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmune diseases. Athos has developed AthosOmics.AI, a proprietary AI-driven drug development platform that resulted in the discovery of...

Amid DHS Shutdown, TSA PreCheck Whiplash, High‑Stakes Spending Fight, and National Security Unrest Chicago, IL, Feb. 24, 2026 (GLOBE NEWSWIRE) — Rick Jordan, CEO of Frequency Holdings, Inc. (OTC: FRQN), host of the top podcast Frequency with Rick Jordan, and creator of the COVID‑era documentary Liberty Lockdown, will appear this week on Tim Pool’s flagship show Timcast IRL, one of YouTube’s most‑watched political talk formats. The episode will air live on Thursday February 26th at 8pm ET, and the conversation will dive into government overreach, the Department of Homeland Security shutdown, and how political games in Washington are colliding with AI, cybersecurity, and everyday American life.Rick Jordan Host of the Top Podcast FREQUENCY with Rick Jordan and CEO of Frequency Holdings (OTC: FRQN) Hosted by journalist and commentator...

HONG KONG, Feb. 24, 2026 (GLOBE NEWSWIRE) — Abits Group Inc (NASDAQ: ABTS) (the “Company”), a new generation digital center with inhouse bitcoin mining operations, today announced the closing of the previously announced registered direct offering with institutional investors of approximately $2.1 million of Ordinary Shares and pre-funded warrants at a price of $2.65 per Ordinary Share. The entire transaction was priced at the market under Nasdaq rules. The offering consisted of the sale of 792,452 Ordinary Shares or Pre-Funded Warrants. The price per Ordinary Share was $2.65 (or $2.64999 for each Pre-Funded Warrant, which is equal to the offering price per Ordinary Share sold in the offering minus an exercise price of $0.00001 per Pre-Funded Warrant). The Pre-Funded Warrants are immediately exercisable and may be exercised at any...

PRESS RELEASE AB SCIENCE ANNOUNCES THE IDENTIFICATION OF A PLASMA BIOMARKER THAT INDICATES THE ACTIVITY OF MASITINIB IN TREATING AMYOTROPHIC LATERAL SCLEROSIS, AND THAT IS CAPABLE OF IDENTIFYING PATIENTS WITH PRO INFLAMATORY MICROGLIA, WHICH ARE TARGETED BY MASITINIB THIS BIOMARKER IS ALSO APPLICABLE TO PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS AND ALZHEIMER DISEASE THIS BIOMARKER CAN BE STRATEGIC TO DETERMINE WHICH PATIENTS RESPOND TO TREATMENT AND POTENTIALLY INCREASE CHANCE OF REGISTRATION IN NEURODEGENERATIVE DISEASES Paris, February 24, 2026, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) announced the identification of a potential biomarker for assessing the activity of masitinib in pathological microglial involvement in Amyotrophic Lateral Sclerosis (ALS). The key characteristics of this newly identified biomarker...

Toll Brothers at Wildtree offers luxury homes with access to premier amenities MAGNOLIA, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced Toll Brothers at Wildtree, a new Houston-area community of one- and two-story homes, is now open in Magnolia, Texas. Located in Montgomery County, this exceptional community features modern home designs on expansive 60-foot-wide home sites. The Toll Brothers Sales Center is now open at 4919 Pinestraw Valley Way in Magnolia.Homes at Toll Brothers at Wildtree range from approximately 3,078 to over 3,600 square feet and offer 4 to 5 bedrooms and 3 to 4.5 baths. With unique architectural details including cathedral ceilings and spiral staircases, these homes provide a perfect blend of style and functionality. Pricing...

OM-Mantra Token Swap, Redenomination and Rebranding – Transformation Event ZUG, Switzerland, Feb. 24, 2026 (GLOBE NEWSWIRE) — Binance has announced that the Digital Asset under the Certificates will be subject to a MANTRA (OM) token swap, redenomination and rebranding to MANTRA (MANTRA):OM tokens will assume the ticker of MANTRA tokens on Binance; All OM tokens will be swapped to MANTRA at a ratio of 1 OM = 4 MANTRA though a non-dilutive split; Implementation is currently expected to take effect on 2 March 2026; and Separately, a trading halt at Spotlight regarding the Certificates is expected to be imposed on 2 March and 3 March 2026 to ensure orderly fair and market conditions.Further information regarding the token swap, redenomination and rebranding is available at: https://www.binance.com/en/support/announcement/detail/4d13052b4be943f5b155cb9150ca902c?utm_source=new_share&ref=CPA_00Q01Y04QJ The...